open access

Vol 53, No 1 (2022)
Editorial
Submitted: 2022-01-17
Accepted: 2022-01-17
Get Citation

Progress in molecular profiling: new recommendations in myelodysplastic syndromes

Jan Styczyński1
DOI: 10.5603/AHP.2022.0002
·
Acta Haematol Pol 2022;53(1):1-2.
Affiliations
  1. Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Jurasz University Hospital 1, Bydgoszcz, Poland

open access

Vol 53, No 1 (2022)
EDITORIAL
Submitted: 2022-01-17
Accepted: 2022-01-17

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Progress in molecular profiling: new recommendations in myelodysplastic syndromes

Journal

Acta Haematologica Polonica

Issue

Vol 53, No 1 (2022)

Article type

Editorial

Pages

1-2

Page views

585

Article views/downloads

95

DOI

10.5603/AHP.2022.0002

Bibliographic record

Acta Haematol Pol 2022;53(1):1-2.

Authors

Jan Styczyński

References (10)
  1. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20): 2391–2405.
  2. Mądry K, Drozd-Sokołowska J, Lis K, et al. Diagnosis of myelodysplastic syndromes in Poland: the Polish Adult Leukemia Group (PALG) 2021 recommendations. Acta Haematol Pol. 2022; 53(1): 3–XX.
  3. Mądry K, Budziszewska BK, Lis K, et al. Treatment of myelodysplastic syndromes in Poland: the Polish Adult Leukemia Group (PALG) 2021 recommendations. Acta Haematol Pol. 2022; 53(2).
  4. Giebel S, Basak G, Bieniaszewska M, et al. Current status and progress of Polish hemato-oncology. Acta Haematol Pol. 2021; 52(1): 4–17.
  5. Antoniewicz-Papis J, Brojer E, Fabijańska-Mitek J, et al. Current status and achievements of Polish transfusion medicine. Acta Haematol Pol. 2021; 52(3): 147–162.
  6. Gil L, Kałwak K, Piekarska A, et al. Antifungal management in adults and children with hematological malignancies or undergoing hematopoietic cell transplantation: recommendations of Polish Society of Hematology and Blood Transfusion, Polish Society of Pediatric Oncology and Hematology, and Polish Adult Leukemia Study Group, 2020. Acta Haematol Pol. 2020; 51(2): 60–72.
  7. Styczynski J, Tridello G, Gil L, et al. Prognostic impact of Epstein-Barr virus serostatus in patients with nonmalignant hematological disorders undergoing allogeneic hematopoietic cell transplantation: the study of Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation. Acta Haematol Pol. 2020; 51(2): 73–80.
  8. Czyżewski K, Sedláček P, Štěrba J, et al. Progress and trends in pediatric hematopoietic cell transplantation in Central-East European countries. Acta Haematol Pol. 2020; 51(3): 142–150.
  9. Jurczyszyn A, Charliński G, Suska A, et al. The importance of cytogenetic and molecular aberrations in multiple myeloma. Acta Haematol Pol. 2021; 52(4): 361–370.
  10. Snowden JA, Styczyński J, Snarski E, et al. Hematopoietic stem cell transplantation in autoimmune diseases: update from EBMT Autoimmune Diseases Working Party with special reference to and. Acta Haematol Pol. 2021; 52(4): 217–224.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl